HIND
Vyome Holdings Inc
NASDAQ · Pharmaceuticals
$2.74
+0.44 (+19.13%)
Open$2.28
Previous Close$2.30
Day High$2.93
Day Low$2.28
52W High$16.71
52W Low$10.37
Volume—
Avg Volume661.9K
Market Cap15.47M
P/E Ratio14.22
EPS$1.12
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+597.8% upside
Current
$2.74
$2.74
Target
$19.12
$19.12
$13.94
$19.12 avg
$23.15
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.00M | 5.84M | 4.87M |
| Net Income | 1.15M | 1.21M | 947.3K |
| Profit Margin | 19.1% | 20.8% | 19.4% |
| EBITDA | 1.77M | 1.81M | 1.57M |
| Free Cash Flow | 589.5K | 575.3K | 579.0K |
| Rev Growth | +1.1% | -9.0% | -7.3% |
| Debt/Equity | 0.84 | 0.79 | 0.79 |
Dividend
Dividend Yield2.34%
Annual Dividend$0.37
Payout Ratio33.3%
Frequencyquarterly
Ex-DividendApr 18, 2026
Pay DateMay 8, 2026
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |